We use cookies to help us improve the website and your experience using it. You may delete and block all cookies from this site at any time. However, please note this may result in parts of the site no longer working correctly. If you continue without changing your settings we will assume you are happy to receive all cookies on this site.

Close

Specimen Acceptance Policy - MMMP

This policy ensures adequate identification criteria for pathology specimens and request forms in order for them to be accepted by the laboratory for analysis.

It is the requester's responsibility to ensure that all details are correct, clearly written and that the specimen details match those on the form and patient wrist band (if applicable).

Inadequately or inaccurately labelled specimens or forms will not be accepted unless they are considered to be 'unrepeatable'.

A classification of 'unrepeatable' will be on an individual basis and in these cases the requester may be required to come to the laboratory to amend their request information and to document that they have done so.

Any labelling discrepancy will be included on the pathology report. Inadequate or inaccurate labelling results in delays before pathology results are available and hence affects patient care.

CENTRAL SITE Mandatory Labelling Requirement Action by Laboratory if requirement not met

Samples MUST be labelled with 4 unique identifiers which are as follows:

  • District number
  • Surname
  • Forename
  • Date of birth

 

The request form (if required) data MUST match the above information on the sample.

 

Multiple samples taken at different times on a patient MUST be labelled on the sample container with the time (24 hr clock) when the sample is taken.

No analysis will be performed. The event will be reported as an incident on Ulysses if appropriate.

Where the sample is repeatable/reproducible, no analysis will be performed and the sample will be discarded.

Where the sample is unrepeatable/unreproducible, the risk to the patient of rejection of the sample must be weighed against the risk of acceptance of a wrongly labelled sample, local procedures will be followed.

Laboratory Medicine will accept no responsibility for samples analysed which initially failed to meet the acceptance criteria and will issue a disclaimer on such reports.

 

If a request form is required then the request form data MUST match the above sample information

  • District number
  • Surname
  • Forename
  • Date of birth

Request forms SHOULD also contain:

  • The patient's location/destination for the report (or a location code)
  • Tests required
  • Name of consultant or GP
  • Name of the requester and contact number (bleep or extension)
  • Patient gender
  • Date and time of sample collection
  • Anatomical site and type of sample (where relevant)
  • All relevant clinical information
  • Patient address for GP requests
  • For Blood Transfusion - forms MUST be signed

A lack of patient or sample information may result in the laboratory not conducting the analysis/examination.

Examples could include:

  • No swab site indicated
  • No dates and times of sampling
  • No clinical details given
  • Location for report delivery not given

It may not be possible to issue a report or to interpret results.

Appropriate comments will be made on the report where this can be issued.

 

 

Anonymous/uniquely identified specimens and requests

In certain circumstances, patient identification details are intentionally hidden or substituted with particular ID numbers (eg. Sexual Health, clinical trials, donor specimens), in such instances, a properly coded identifier must be used in place of the patient last name and first name.

Clinical and epidemiological information

To ensure samples can be safely and appropriately tested in the laboratory, information including details of foreign travel, symptoms and known or suspected contact with other patients known to have communicable disease is important.

For example, samples likely to contain high risk pathogens [as described by the Advisory Committee for Dangerous Pathogens] are handled at a higher containment level to safeguard both laboratory staff and other downstream workers.

The information is also of benefit to the patient ensuring that appropriate testing is performed to safeguard the patient and benefit their patient journey.